Fig. 3From: Significant suppression of radiation dermatitis in breast cancer patients using a topically applied adrenergic vasoconstrictorSubject 2004. NG12-1 treatment area (ink marks) showing reduced radiodermatis on Day 30 (Panel a) and Day 35 (Panel b). The interim analysis score was +++Back to article page